Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-02

Clinical Trial Update: Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sugammadex to neostigmine with glycopyrrolate for postoperative urinary retention after spine surgery; currently enrolling by invitation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine with glycopyrrolate (Neostigmine; Glycopyrrolate)
  • Sugammadex (sugammadex)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Spine Surgery, Reversal of Neuromuscular Blockade | Phase 4 | Status: ENROLLING_BY_INVITATION